GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (HKSE:00775) » Definitions » E10

CK Life Sciences International Holdings (HKSE:00775) E10 : HK$0.02 (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is CK Life Sciences International Holdings E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

CK Life Sciences International Holdings's adjusted earnings per share data for the fiscal year that ended in Dec. 2023 was HK$0.002. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is HK$0.02 for the trailing ten years ended in Dec. 2023.

During the past 5 years, the average E10 Growth Rate was -8.90% per year. During the past 10 years, the average E10 Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of CK Life Sciences International Holdings was 44.20% per year. The lowest was -12.60% per year. And the median was 20.25% per year.

As of today (2024-05-20), CK Life Sciences International Holdings's current stock price is HK$ 0.42. CK Life Sciences International Holdings's E10 for the fiscal year that ended in Dec. 2023 was HK$0.02. CK Life Sciences International Holdings's Shiller PE Ratio of today is 21.00.

During the past 13 years, the highest Shiller PE Ratio of CK Life Sciences International Holdings was 93.00. The lowest was 11.33. And the median was 36.50.


CK Life Sciences International Holdings E10 Historical Data

The historical data trend for CK Life Sciences International Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings E10 Chart

CK Life Sciences International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.02 0.02 0.02 0.02

CK Life Sciences International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 - 0.02 - 0.02

Competitive Comparison of CK Life Sciences International Holdings's E10

For the Biotechnology subindustry, CK Life Sciences International Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Shiller PE Ratio falls into.



CK Life Sciences International Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CK Life Sciences International Holdings's adjusted earnings per share data for the fiscal year that ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.002/117.2957*117.2957
=0.002

Current CPI (Dec. 2023) = 117.2957.

CK Life Sciences International Holdings Annual Data

per_share_eps CPI Adj_EPS
201412 0.027 99.707 0.032
201512 0.023 102.015 0.026
201612 0.026 103.225 0.030
201712 0.027 104.984 0.030
201812 0.027 107.622 0.029
201912 0.019 110.700 0.020
202012 0.013 109.711 0.014
202112 0.017 112.349 0.018
202212 0.014 114.548 0.014
202312 0.002 117.296 0.002

Add all the adjusted EPS together and divide 10 will get our e10.


CK Life Sciences International Holdings  (HKSE:00775) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

CK Life Sciences International Holdings's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=0.42/0.02
=21.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of CK Life Sciences International Holdings was 93.00. The lowest was 11.33. And the median was 36.50.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


CK Life Sciences International Holdings E10 Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


CK Life Sciences International Holdings (HKSE:00775) Business Description

Traded in Other Exchanges
Address
2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (HKSE:00775) Headlines

No Headlines